Det skrivs lite om 2X-121 i senaste news från NAU.https://chamberbusinessnews.com/2020/05/27/northern-arizona-university-tackles-pandemic-readies-for-fall-opening/
“The COVID-19 pandemic is a crisis that requires the whole scientific community working together to find fast, cheap, and effective solutions to the problem. Our ability to redirect the PMI BSL-3 facilities to COVID-19 research is a small but important part of the nation’s path forward,” said PMI Executive Director and Regents’ Professor Paul Keim, a world expert in pathogens. Keim worked with the FBI to crack the “anthrax letters” case in the wake of 9/11.
The first therapeutic agent being tested against the virus is the promising cancer drug 2X-121, developed by the Danish firm Oncology Venture, which recently signed a joint research agreement with PMI and NAU to evaluate it.
Although highly-trained staff members will conduct much of the research with the virus, undergraduate and graduate students will be involved in supporting roles.